Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Nektar Starts Major Push In Opioid-Induced Constipation Space

Mar 16 2009

• By Emily Hayes

Related Content

Nektar/Bayer Agree To Develop Inhaled Amikacin For Hospital-Acquired Pneumonia

Aug 06 2007

Door Open For Zelnorm Return Despite Marketing “Suspension,” Novartis Says

Apr 02 2007

FDA’s Strongest REMS To Date: Entereg Approved With Controlled-Distribution

May 26 2008

Adolor Seeks New Entereg Partner; Asks FDA To Weigh In On Chronic Use

Sep 02 2008

Wyeth/Progenics’ Relistor: FDA Says Yes, EU Likes It, Too

Apr 24 2008

Niche, Lackluster: Two Words That Sum Up 2008 NME Launches

Jan 12 2009

Who Stays, Who Goes? Tricky Guessing On Wyeth/Pfizer’s Keeper Deals

Feb 09 2009

Adolor Faces R&amp;D Setbacks, One With Entereg

Dec 18 2008

Pharma's R&D Heartburn Spells Opportunity for GI-Focused Biotechs

Nov 01 2007

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window